Compare Heron Therapeutics Inc (HRTX) vs Ross Stores, Inc. (ROST) Price & Performance

HRTX trades at $0.4804, up 2.06% today, with a bullish technical signal despite mixed earnings. The stock shows a low price-to-sales ratio of 0.51 but negative profitability, with a net income margin of -20.53% in 2026. Recent Q1 2026 earnings missed expectations, though management reaffirmed full-year guidance. Analyst consensus is strongly bullish with 94.7% buy ratings.

Outlook remains speculative given persistent losses and cash burn, but potential upside exists if operational improvements materialize. Key risks include patent litigation outcomes and reliance on revenue growth to achieve profitability. Investors should weigh high analyst optimism against fundamental challenges.

Ross Stores (ROST) trades at $235.36, up 0.87% with strong technical and fundamental momentum. The stock shows bullish moving averages and recent earnings beats, with Q1 2026 EPS of $2.02 exceeding expectations by 17%. Revenue growth accelerated to $21.13B in 2025, while net income margin improved to 9.74%. Analyst sentiment remains positive with a $259 consensus target, supported by robust store expansion and customer acquisition trends noted in recent media coverage.

Outlook is favorable given consistent earnings outperformance and high ROE of 38.98%, though valuation multiples like P/E of 32.6 suggest premium pricing. Key risks include consumer spending sensitivity and competitive pressures in off-price retail. Institutional ownership trends and technical support near $232 provide a cushion for near-term stability.